FDA Inspection
Michael J. Downing, M.D.Michael J. Downing, M.D. – FDA Inspection, May 30, 2018
Record Details
This FDA Inspection record concerns Michael J. Downing, M.D., with an inspection on May 30, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 627efa92-471b-40cf-8c7f-b5d1b45e2237
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1055101
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Michael J. Downing, M.D.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 12, 2025 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| July 15, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 22, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Michael J. Downing, M.D.
- FDA Inspection 1261914 - 2025-02-12
- FDA Inspection 1146849 - 2021-07-15
- FDA Inspection 1102682 - 2019-08-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.